Dr. Joseph Scalea

Steven Hanish is a Transplant Surgeon and a General Surgeon in Charleston, South Carolina. Dr. Hanish is highly rated in 4 conditions, according to our data. His top areas of expertise are Liver Failure, Alcoholic Cirrhosis, Hepatitis, Liver Transplant, and Hepatectomy.

Dr. Adrian Van Bakel graduated from the University of Louisville School of Medicine in 1981, completing a Ph.D. in pharmacology from that institution in 1983. He completed internal medicine residency and cardiology fellowship training at the Medical University of South Carolina and has been on the faculty at MUSC since 1991. Dr. Van Bakel served as the Medical Director of the Heart Failure and Cardiac Transplant Program from 1991-2017. He has been an integral part of a multi-disciplinary clinical team that has achieved excellent results in the areas of clinical heart failure management and cardiac transplantation. He is a member of a number of professional societies including: The American College of Physicians; the American Heart Association; the American College of Cardiology; the Heart Failure Society of America; and, the International Society of Heart and Lung Transplantation. He has served as a manuscript reviewer for several journals, such as: The Journal of Cardiac Failure; The Journal of Heart and Lung Transplantation; and, The American Journal of Transplantation. Dr. Van Bakel has been the principal investigator of many multi-center clinical trials in congestive heart failure and cardiac transplantation. His research interests include congestive heart failure management, novel immunosuppression strategies and the pharmacogenomics of drug absorption and metabolism. Dr. Van Bakel is highly rated in 7 conditions, according to our data. His top areas of expertise are Pulmonary Edema, Heart Failure, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Ablation, and Endoscopy.

Diego di Sabato, M.D., serves as the Surgical Director of Liver Transplantation for both adult and pediatric patients at MUSC, a position that allows him to make a significant impact on patient care. He is developing a robust Living Donor Liver Transplant (LDLT) program and works with multidisciplinary teams including MUSC Health's Transplant Oncology practice, the Pediatric Liver Transplant Program, and other LDLT indications.Dr. di Sabato joined MUSC from the University of Chicago School of Medicine, where, since 2019, he served as the co-director of the Living Donor Liver Transplant (LDLT) Program. During his tenure at the University of Chicago School of Medicine, he relaunched the LDLT program after a 5-year hiatus, building it into one of the busiest LDLT programs in the region, with surgical outcomes that have met or exceeded national standards. As a pediatric transplant surgeon, he integrated live donor liver transplants and established a multidisciplinary approach to pediatric liver diseases, with excellent outcomes considering the complex population. The impact of the LDLT program now contributes to more than half of the pediatric liver transplants, including for acute liver failure in children, as well as an essential component of their novel Transplant Oncology program.Dr. di Sabato is exceedingly well trained, having completed two fellowships in Transplantation at Northwestern University Feinberg School of Medicine. He was also a visiting surgeon at the world's busiest living donor liver transplant program, Asan Medical Center, in Seoul, South Korea, the first center in the world to perform living donor liver transplantation.Along with his dedication to his clinical work, Dr. di Sabato is passionate about continued research to improve care for transplant patients. Currently, he is investigating liver recovery options in order to increase the number of viable organs available for patients needing a liver transplant. Dr. Di Sabato is highly rated in 2 conditions, according to our data. His top areas of expertise are Hepatitis, Liver Cancer, Fibrolamellar Carcinoma, Liver Transplant, and Kidney Transplant.